Search results
Results from the WOW.Com Content Network
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
tuberculosis patient. Tuberculosis in India is a ... estimates, India has the world ... India has a large burden of the world's TB, with an estimated economic cost of ...
It is not unusual for patients with MDR-TB to be on treatment for two years or more. Patients with MDR-TB should be isolated in negative-pressure rooms, if possible. Patients with MDR-TB should not be accommodated on the same ward as immunosuppressed patients (HIV infected patients, or patients on immunosuppressive drugs). Careful monitoring of ...
The Global Plan to End TB, 2023-2030 [6] is a plan for ending TB as a public health challenge by 2030. It is produced by the Stop TB partnership and provides a blueprint of priority actions required and a detailed estimate of financial resources needed to end TB.
The cost of treating a single case of multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB) can be thousands of times more expensive than treating drug-sensitive TB. [ 7 ] TB is also the number one killer of people with AIDS , but it is generally agreed that current TB treatments do not work well with the antiretroviral ...
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, [7] is a contagious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. [1] Tuberculosis generally affects the lungs , but it can also affect other parts of the body. [ 1 ]
The report was a costing analysis of health system strengthening in order to meet the Millennium Development Goals by 2015, and relied on WHO-CHOICE data and published WHO-CHOICE work for some specific cost estimates. It is cited on the WHO-CHOICE website as an example of the use of WHO-CHOICE to generate Global Price Tags.